Mwg Management Ltd. Beam Therapeutics Inc. Transaction History
Mwg Management Ltd.
- $74.4 Million
- Q4 2024
A detailed history of Mwg Management Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mwg Management Ltd. holds 2,266,934 shares of BEAM stock, worth $69 Million. This represents 75.61% of its overall portfolio holdings.
Number of Shares
2,266,934
Previous 2,266,934
-0.0%
Holding current value
$69 Million
Previous $55.5 Million
1.22%
% of portfolio
75.61%
Previous 61.51%
Shares
4 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$251 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$232 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$232 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$215 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$138 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.14B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...